A Study to Evaluate the Effect of the Potent Cytochrome P-450 3A4 (CYP3A4) Inhibitor Itraconazole on the Pharmacokinetics (PK) of TAK-954 in Healthy Adult Participants
Clinical trial NCT03173170 · COMPLETED
Trial details
- NCT number
- NCT03173170
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-31
- Primary completion
- 2017-07-24
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.